Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Stewart, Taryn P ^a   Kim, Hyoung Y ^b   Saxton, Arnold M ^b   Kim, Jung H ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; TRIACYLGLYCEROL; APOLIPOPROTEIN A2;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOA2 GENE; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CARCASS; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 8; DISEASE MODEL; F2 MOUSE; FEMALE; GENE; GENE EXPRESSION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MALE; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PHENOTYPE; QUANTITATIVE TRAIT LOCUS MAPPING; SEQUENCE ANALYSIS; TALLYHO JNGJ MOUSE; ADIPOSE TISSUE; ANIMAL; BLOOD; CROSS BREEDING; EXPERIMENTAL DIABETES MELLITUS; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETICS; GENOME; MOLECULAR GENETICS; ORGAN SIZE; PATHOLOGY; QUANTITATIVE TRAIT LOCUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEIN A-II; BASE SEQUENCE; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; CROSSES, GENETIC; DIABETES MELLITUS, EXPERIMENTAL; EPISTASIS, GENETIC; FEMALE; GENOME; GENOME-WIDE ASSOCIATION STUDY; HYPERLIPIDEMIAS; INSULIN; MALE; MICE; MOLECULAR SEQUENCE DATA; OBESITY; ORGAN SIZE; PHENOTYPE; QUANTITATIVE TRAIT LOCI; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 78650214179     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-713     Document Type: Article

References (42)

1. Romao I, Roth J. Genetic and environmental interactions in obesity and type 2 diabetes. J Am Diet Assoc 2008, 108:S24-S28. 10.1016/j.jada.2008.01.022, 18358250.
2. Tomkin GH. Targets for intervention in dyslipidemia in diabetes. Diabetes Care 2008, 31(Suppl 2):S241-S248. 10.2337/dc08-s260, 18227492.
3. Pearson ER. Recent advances in the genetics of diabetes. Prim Care Diabetes 2008, 2:67-72. 10.1016/j.pcd.2007.12.005, 18684425.
4. Ridderstråle M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endorinol 2009, 297:10-17.
5. Kim JH, Sen S, Avery CS, Simpson E, Chandler P, Nishina PM, Churchill GA, Naggert JK. Genetic analysis of a new mouse model for non-insulin-dependent diabetes. Genomics 2001, 74:273-286. 10.1006/geno.2001.6569, 11414755.
6. Kim JH, Stewart TP, Soltani-Bejnood M, Wang L, Fortuna JM, Mostafa OA, Moustaid-Moussa N, Shoieb AM, McEntee MF, Wang Y, Bechtel L, Naggert JK. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice. J Endocrinol 2006, 191:437-446. 10.1677/joe.1.06647, 17088413.
7. Wang Y, Nishina PM, Naggert JK. Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng. J Endocrinol 2009, 203:65-74. 10.1677/JOE-09-0026, 2853731, 19587264.
8. Didion SP, Lynch CM, Faraci FM. Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes. Am J Physiol Heart Circ Physiol 2007, 292:H1579-H1583. 10.1152/ajpheart.00939.2006, 17122191.
9. Cheng ZJ, Jiang YF, Ding H, Severson D, Triggle CR. Vascular dysfunction in type 2 diabetic TallyHo mice: role for an increase in the contribution of PGH2/TxA2 receptor activation and cytochrome p450 products. Can J Physiol Pharmacol 2007, 85:404-412. 10.1139/Y07-010, 17612649.
10. Drake TA, Schadt EE, Lusis AJ. Integrating genetic and gene expression data: application to cardiovascular and metabolic traits in mice. Mamm Genome 2006, 17:466-479. 10.1007/s00335-005-0175-z, 2679634, 16783628.
11. Doss S, Schadt EE, Drake TA, Lusis AJ. Cis-acting expression quantitative trait loci in mice. Genome Res 2005, 15:681-691. 10.1101/gr.3216905, 1088296, 15837804.
12. Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 1993, 261:469-472. 10.1126/science.8332912, 8332912.
13. Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 1993, 365:762-764. 10.1038/365762a0, 8413656.
14. Castellani LW, Goto AM, Lusis AJ. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes 2001, 50:643-651. 10.2337/diabetes.50.3.643, 11246886.
15. Moore KJ, Nagle DL. Complex trait analysis in the mouse: The strengths, the limitations and the promise yet to come. Annu Rev Genet 2000, 34:653-686. 10.1146/annurev.genet.34.1.653, 11092842.
16. Darvasi A, Weinreb A, Minke V, Weller JI, Soller M. Detecting marker-QTL linkage and estimating QTL gene effect and map location using a saturated genetic map. Genetics 1993, 134:943-951. 1205528, 8349116.
17. Wang X, Korstanje R, Higgins D, Paigen B. Haplotype analysis in multiple crosses to identify a QTL gene. Genome Res 2004, 14:1767-1772. 10.1101/gr.2668204, 515323, 15310659.
18. Kitagawa K, Wang J, Mastushita T, Kogishi K, Hosokawa M, Fu X, Guo Z, Mori M, Higuchi K. Polymorphisms of mouse apolipoprotein A-II: seven alleles found among 41 inbred strains of mice. Amyloid 2003, 10:207-214.
19. Suto J, Takahashi Y, Sekikawa K. Quantitative trait locus analysis of plasma cholesterol and triglyceride levels in C57BL/6J × RR F2 mice. Biochem Genet 2004, 42:347-363. 10.1023/B:BIGI.0000039809.40228.d3, 15524312.
20. Nobrega MA, Solberg Woods LC, Fleming S, Jacob HJ. Distinct genetic regulation of progression of diabetes and renal disease in the Goto-Kakizaki rat. Physiol Genomics 2009, 39:38-46. 10.1152/physiolgenomics.90389.2008, 19584172.
21. Lasky-Su J, Lyon HN, Emilsson V, Heid IM, Molony C, Raby BA, Lazarus R, Klanderman B, Soto-Quiros ME, Avila L, Silverman EK, Thorleifsson G, Thorsteinsdottir U, Kronenberg F, Vollmert C, Illig T, Fox CS, Levy D, Laird N, Ding X, McQueen MB, Butler J, Ardlie K, Papoutsakis C, Dedoussis G, O'Donnell CJ, Wichmann HE, Celedón JC, Schadt E, Hirschhorn J, Weiss ST, Stefansson K, Lange C. On the replication of genetic associations: timing can be everything!. Am J Hum Genet 2008, 82:849-858. 10.1016/j.ajhg.2008.01.018, 2427263, 18387595.
22. Wang SS, Schadt EE, Wang H, Wang X, Ingram-Drake L, Shi W, Drake TA, Lusis AJ. Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circ Res 2007, 101:e11-30. 10.1161/CIRCRESAHA.107.152975, 17641228.
23. Ishimori N, Li R, Kelmenson PM, Korstanje R, Walsh KA, Churchill GA, Forsman-Semb K, Paigen B. Quantitative trait loci analysis for plasma HDL-cholesterol concentrations and atherosclerosis susceptibility between inbred mouse strains C57BL/6J and 129S1/SvImJ. Arterioscler Thromb Vasc Biol 2004, 24:161-166. 10.1161/01.ATV.0000104027.52895.D7, 14592847.
24. Korstanje R, Eriksson P, Samnegård A, Olsson PG, Forsman-Semb K, Sen S, Churchill GA, Rollins J, Harris S, Hamsten A, Paigen B. Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans. Atherosclerosis 2004, 177:443-450. 10.1016/j.atherosclerosis.2004.08.006, 15530921.
25. Fujimoto K, Koishi R, Shimizugawa T, Ando Y. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp Anim 2006, 55:27-34. 10.1538/expanim.55.27, 16508209.
26. Shike T, Hirose S, Kobayashi M, Funabiki K, Shirai T, Tomino Y. Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model. Diabetes 2001, 50:1943-1948. 10.2337/diabetes.50.8.1943, 11473059.
27. Schmidt C, Gonzaludo NP, Strunk S, Dahm S, Schuchhardt J, Kleinjung F, Wuschke S, Joost HG, Al-Hasani H. A meta-analysis of QTL for diabetes-related traits in rodents. Physiol Genomics 2008, 34:42-53. 10.1152/physiolgenomics.00267.2007, 18397992.
28. Scherneck S, Nestler M, Vogel H, Blüher M, Block MD, Diaz MB, Herzig S, Schulz N, Teichert M, Tischer S, Al-Hasani H, Kluge R, Schürmann A, Joost HG. Positional cloning of zinc finger domain transcription factor Zfp69, a candidate gene for obesity-associated diabetes contributed by mouse locus Nidd/SJL. PLoS Genet 2009, 5:e1000541. 10.1371/journal.pgen.1000541, 2696593, 19578398.
29. Wuschke S, Dahm S, Schmidt C, Joost HG, Al-Hasani H. A meta-analysis of quantitative trait loci associated with body weight and adiposity in mice. Int J Obes (Lond) 2007, 31:829-841.
30. Corva PM, Horvat S, Medrano JF. Quantitative trait loci affecting growth in high growth (hg) mice. Mamm Genome 2001, 12:284-290. 10.1007/s003350010275, 11309659.
31. Vogel H, Nestler M, Rüschendorf F, Block MD, Tischer S, Kluge R, Schürmann A, Joost HG, Scherneck S. Characterization of Nob3, a major quantitative trait locus for obesity and hyperglycemia on mouse chromosome 1. Physiol Genomics 2009, 38:226-232. 10.1152/physiolgenomics.00011.2009, 2712221, 19470805.
32. Rocha JL, Eisen EJ, Van Vleck LD, Pomp D. A large-sample QTL study in mice: I. Growth. Mamm Genome 2004, 15:83-99. 10.1007/s00335-003-2312-x, 15058380.
33. Morris KH, Ishikawa A, Keightley PD. Quantitative trait loci for growth traits in C57BL/6J × DBA/2J mice. Mamm Genome 1999, 10:225-228. 10.1007/s003359900977, 10051315.
34. Huber J, Kiefer FW, Zeyda M, Ludvik B, Silberhumer GR, Prager G, Zlabinger GJ, Stulnig TM. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab 2008, 93:3215-3221. 10.1210/jc.2007-2630, 18492752.
35. Kim JH, Stewart TP, Zhang W, Kim HY, Nishina PM, Naggert JK. Type 2 diabetes mouse model TallyHo carries an obesity gene on chromosome 6 that exaggerates dietary obesity. Physiol Genomics 2005, 22:171-181. 10.1152/physiolgenomics.00197.2004, 15870394.
36. Darvasi A. Experimental strategies for the genetic dissection of complex traits in animal models. Nat Genet 1998, 18:19-24. 10.1038/ng0198-19, 9425894.
37. Strauss WM. Preparation of genomic DNA from mammalian tissue. Current Protocols in Molecular Biology 1998, 2.2.1-2.2.3. J. Wiley & Sons, Inc..
38. Dalen KT, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI. Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver × receptor alpha. J Biol Chem 2003, 278:48283-48291. 10.1074/jbc.M302287200, 12970362.
39. Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics 2003, 19:889-890. 10.1093/bioinformatics/btg112, 12724300.
40. Wolfinger RD, Gibson G, Wolfinger E, Bennett L, Hamadeh H, Bushel P, Afshari C, Paules RS. Assessing gene significance from cDNA microarray expression data via mixed models. J Comput Biol 2001, 8:625-637. 10.1089/106652701753307520, 11747616.
41. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003, 19:368-375. 10.1093/bioinformatics/btf877, 12584122.
42. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.